ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Obstructive Sleep Apnea Treatment on Dizziness, Vertigo (OSATDV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02685579
Recruitment Status : Withdrawn
First Posted : February 18, 2016
Last Update Posted : December 28, 2016
Sponsor:
Information provided by (Responsible Party):
Oron Yahav, Wolfson Medical Center

Brief Summary:
Obstructive Sleep Apnea may cause dizziness or vertigo through hypoxia of the vestibular nuclei in the brain. Treating sleep apnea may improve dizziness or vertigo.

Condition or disease Intervention/treatment
Sleep Apnea Dizziness Vertigo Other: Treatment of Obstructive Sleep Apnea-CPAP/BiPAP etc./Diet/surgery/life style changes

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Effect of Obstructive Sleep Apnea Treatment on Dizziness, Vertigo
Study Start Date : June 2016
Estimated Primary Completion Date : March 2018

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Dizziness Handicap Inventory Score [ Time Frame: 3 months ]
    A change in the DHI score after treatment (before treatment and after, 3 months in between)


Secondary Outcome Measures :
  1. Romberg on foam test [ Time Frame: 3 months ]
    A change in the time participants will stand without falling on a foam (before treatment and after, 3 months in between)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People coming to the Sleep Study Laboratory at the E. Wolfson Medical Center
Criteria

Inclusion Criteria:

  • Over 18 years old
  • Diagnosed with Sleep Apnea
  • DHI score equals or over 16 points

Exclusion Criteria:

  • Pregnant women
  • Patients diagnosed with mental diseases
  • Patients taking anti-vertigo medications
  • Patients after CVA or with peripheral neuropathy
  • Patients who suffered severe head trauma
  • Patients with chronic renal failure
  • Patients with malignancy at the time of the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02685579


Locations
Israel
Wolfson Medical Centre
Holon, Israel
Sponsors and Collaborators
Wolfson Medical Center

Responsible Party: Oron Yahav, ENT Specialist, Wolfson Medical Center
ClinicalTrials.gov Identifier: NCT02685579     History of Changes
Other Study ID Numbers: 0103-15-WOMC
First Posted: February 18, 2016    Key Record Dates
Last Update Posted: December 28, 2016
Last Verified: December 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Additional relevant MeSH terms:
Vestibular Diseases
Apnea
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Vertigo
Dizziness
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Labyrinth Diseases
Ear Diseases
Otorhinolaryngologic Diseases
Neurologic Manifestations
Sensation Disorders